208 related articles for article (PubMed ID: 18164870)
1. In vivo dosimetry of high-dose-rate interstitial brachytherapy in the pelvic region: use of a radiophotoluminescence glass dosimeter for measurement of 1004 points in 66 patients with pelvic malignancy.
Nose T; Koizumi M; Yoshida K; Nishiyama K; Sasaki J; Ohnishi T; Kozuka T; Gomi K; Oguchi M; Sumida I; Takahashi Y; Ito A; Yamashita T
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):626-33. PubMed ID: 18164870
[TBL] [Abstract][Full Text] [Related]
2. In vivo dosimetry of high-dose-rate brachytherapy: study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter.
Nose T; Koizumi M; Yoshida K; Nishiyama K; Sasaki J; Ohnishi T; Peiffert D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):945-53. PubMed ID: 15708279
[TBL] [Abstract][Full Text] [Related]
3. [Dosimetry of interstitial brachytherapy using radiophotoluminescence glass: On absorbed dose of anterior wall of the rectum].
Nose T; Koizumi M; Nishiyama K; Yoshida K
Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Sep; 61(10):540-2. PubMed ID: 11676171
[TBL] [Abstract][Full Text] [Related]
4. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
Neill M; Studer G; Le L; McLean M; Yeung I; Pond G; Crook JM
Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239
[TBL] [Abstract][Full Text] [Related]
5. In vivo dosimetry using a linear Mosfet-array dosimeter to determine the urethra dose in 125I permanent prostate implants.
Bloemen-van Gurp EJ; Murrer LH; Haanstra BK; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):314-21. PubMed ID: 19100925
[TBL] [Abstract][Full Text] [Related]
6. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
[TBL] [Abstract][Full Text] [Related]
7. An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry.
Toye W; Das R; Kron T; Franich R; Johnston P; Duchesne G
Radiother Oncol; 2009 May; 91(2):243-8. PubMed ID: 18954914
[TBL] [Abstract][Full Text] [Related]
8. [Dosimetry of the bladder and the rectum: comparison between the measured and calculated dose (author's transl)].
Pizzi G; Maluta S; Polico C; Calzavara F; Loreggian L; Fabbris R; Cauzzo C; Nibale O; Francescon P
Radiol Med; 1981 Oct; 67(10):743-7. PubMed ID: 7323338
[TBL] [Abstract][Full Text] [Related]
9. Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques.
Jacob D; Raben A; Sarkar A; Grimm J; Simpson L
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):820-7. PubMed ID: 18455325
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience.
Jabbari S; Hsu IC; Kawakami J; Weinberg VK; Speight JL; Gottschalk AR; Roach M; Shinohara K
Brachytherapy; 2009; 8(4):339-44. PubMed ID: 19428310
[TBL] [Abstract][Full Text] [Related]
11. Rectum dose analysis employing a multi-purpose brachytherapy phantom.
Huh H; Kim W; Loh JJ; Lee S; Kim CY; Lee S; Shin D; Shin D; Cho S; Jang J; Lim S; Cho KH; Kwon S; Kim S
Jpn J Clin Oncol; 2007 May; 37(5):391-8. PubMed ID: 17538010
[TBL] [Abstract][Full Text] [Related]
12. In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125.
Bloemen-van Gurp EJ; Haanstra BK; Murrer LH; van Gils FC; Dekker AL; Mijnheer BJ; Lambin P
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1266-72. PubMed ID: 19665317
[TBL] [Abstract][Full Text] [Related]
13. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry.
Tanderup K; Christensen JJ; Granfeldt J; Lindegaard JC
Radiother Oncol; 2006 Apr; 79(1):87-93. PubMed ID: 16546281
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
[TBL] [Abstract][Full Text] [Related]
15. Comparison of calculated dose by helical tomotherapy treatment planning machine and measured dose of radiophotoluminescence glass dosimeter in lung lesions using Rando Phantom.
Yamazaki H; Iwama K; Nishimura T; Iwai Y; Aibe N; Takenaka T; Miyake S; Tanaka E; Yoshida K; Oota Y; Ikeno H; Nakamura S; Okabe H
Anticancer Res; 2013 Apr; 33(4):1679-84. PubMed ID: 23564815
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of anal radiation in high-dose-rate brachytherapy for prostate cancer.
Kälkner KM; Bengtsson E; Eriksson S; Holmberg C; Nilsson S; Levitt S; Lundell M
Brachytherapy; 2007; 6(1):49-52. PubMed ID: 17284386
[TBL] [Abstract][Full Text] [Related]
17. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
18. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
[TBL] [Abstract][Full Text] [Related]
19. Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer.
Chajon E; Dumas I; Touleimat M; Magné N; Coulot J; Verstraet R; Lefkopoulos D; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):955-61. PubMed ID: 17889277
[TBL] [Abstract][Full Text] [Related]
20. In vivo dosimetry in the urethra using alanine/ESR during (192)Ir HDR brachytherapy of prostate cancer--a phantom study.
Anton M; Wagner D; Selbach HJ; Hackel T; Hermann RM; Hess CF; Vorwerk H
Phys Med Biol; 2009 May; 54(9):2915-31. PubMed ID: 19384000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
